L8.2 Ischemic heart disease Flashcards
1
Q
How is coronary flow increased?
A
- Prolonged diastole → increases oxygen supply to the heart (coronary blood travels with diastole)
- Dilate coronary A
2
Q
What is O2 demand dependent on?
A
- CO (workload)
- Preload (compliance)
- Afterload (resistance)
3
Q
Definition of angina?
A
- Imbalance b/w o2 demand and supply
- Insufficient O2 to meet cardiac demand (due to lack of perfusion)
4
Q
What are the 3 types of angina?
A
- Stable angina (classic)
- Chest pain with exertion/stress (demands met at rest)
- Associated with coronary A disease
- Variant angina (vasospastic)
- Coronary vasospasm at rest
- Mediator unknown
- Cannot treat well
- Unstable angina (crescendo)
- Angina at rest and with effort
- Potential for thrombus formation
5
Q
Features of stable angina?
A
- Normally → dilation of A during exercise to increase flow to meet demands
- Angina occurs due to → already dilated at rest, no reserve dilation (due to low compliance) during exercise
- Increase O2 demands not met with increase BF
6
Q
Aims of prevention for stable angina?
A
- Prevent attacks/relieve symptoms/prevent progression to MI
- Use drugs to increase O2 supply (hard → cannot increase arteriole size) & decrease O2 demand
7
Q
Treating stable angina - by increase O2 supply
A
- Dilate coronary A
- Hard → may already be maximally dilated and has low compliance
- Reduce HR
- Longer diastole phase → coronary A have longer time to fill
8
Q
Treating stable angina - by decreasing O2 demands
A
- Decrease CO (ß-adrenoceptor antagonists/Ca channel blockers/ivabradine(targets HR specifically))
- Decrease HR & SV
- Reduce preload (nitrates)
- Dilate veins/reduce venous return
- Reduce afterload (Ca channel blockers)
- Dilate arterioles, decrease resistance for heart to pump against
9
Q
Mechanism of nitrates
A
10
Q
Features of Nitrate
A
- Is usually a prodrug
- Mimicks endogenous procress (releasing NO)
- Guanylate cyclase → GTP into cGMP → MLC (myosin light chain) dephosphorylate form (unable to interact with actin) → vascular relaxation
- Nitrates can affect all vessels
- Predominant effect on the veins (decrease preload through vasodilations)
11
Q
GTN
A
- short acting
- Routes of administration
- Undergo significant first pass metabolism (cannot be taken orally)
- Taken sublingually → to relieve acute attack
- Transdermal patch → for prophylaxis (prevention)
- I.v. → for emergency
- Unstable drug
- Cannot be stored in plastic (absorbed by plastic → decrease activity) and has to be stored in the dark
12
Q
Isosorbide dinitrate
A
- longer acting
- Used orally for anticipation of effort or prophylaxtically
13
Q
Nitrate SE
A
- Brief relaxation of gut/airways (not much clin significance)
- Postural hypotension (form venous pooling)
- Headache/flushing - from arterial dilations
- Small reflex tachycardia
- Usually used in combination with b-blockers or Ca channel blockers to minimise effect
14
Q
Nitrate drug interactions
A
- Viagra is a phosphodiesterase inhibitor
- Phosphodiesterase breaks down cGMP
- Viagra + GTN → significant cGMP levels → too much venousdilation → may have fatally low VR
15
Q
How does tolerance of nitrates develop
A
- Classic mechanism involves depletion of tissue thiols required for NO production from GTN
- Increase sensitivity of other constrictors (e.g. ANGII/A)
- Increase endothelial free radical production scavenging NO → reduce NO bioavailability
- Reduced acitivity of muscle mitochondrial enz → decrease NO production and increase free radicals
Tolerance develops with continuous use